Delivery Order SPE2DR25D3103-SPE2DR26F9R96
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,980.71 to AmerisourceBergen Drug Corp for Vemlidy 25 mg tablets (30-count units) on November 3, 2025, with completion targeted for November 4, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the prime contractor at its corporate office location in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger indefinite delivery contract...
- The Defense Logistics Agency awarded a $2,511.19 delivery order to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of Vemlidy 25 mg tablets (30-count units). This is a firm fixed-price delivery order with an ultimate completion date of October 22, 2025, and carries no set-aside designation, indicating it was competitively awarded. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order valued at $10,603.39 to AmerisourceBergen Drug Corp for Vemlidy 25 mg tablets (30-count units) on December 17, 2025, with an ultimate completion date of December 18, 2025. This is a firm fixed-price delivery order with no set-aside designation, performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement supporting federal medical supply needs. This delivery order is issued...
- The Defense Logistics Agency awarded a $15,526.22 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Vemlidy 25 mg tablets (30-count units) with an ultimate completion date of November 18, 2025. This non-set-aside competitive award leverages AmerisourceBergen's position as a critical pharmaceutical distributor within the federal medical supply chain. The contractor's corporate office is located in Conshohocken, Pennsylvania, which serves as the place of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Vemlidy 25 mg tablets (30-count units) under a firm fixed-price contract valued at $12,049.24. This is a non-set-aside competitive award with an ultimate completion date of September 19, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Vemlidy 25 mg tablets (30-count units) with a ceiling value of $7,213.88. This firm fixed-price delivery order, which is not set-aside, represents a single transaction under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.99 billion through December 2026. The vendor, headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $6,057.57 to AmerisourceBergen Drug Corp for the supply of Vemlidy 25 mg tablets (30-count units) with a completion date of December 2, 2025. This firm fixed-price contract, awarded December 1, 2025, represents a non-set-aside competitive award to support federal pharmaceutical procurement needs. AmerisourceBergen's Conshohocken, Pennsylvania facility will serve as the place of performance for this delivery order. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $6,832.55 to AmerisourceBergen Drug Corp for Vemlidy 25 mg tablets (30-count unit) on October 27, 2025, with completion scheduled for October 28, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a small-value pharmaceutical procurement supporting federal medical supply requirements. The product will be delivered to AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a $7,299.76 delivery order to AmerisourceBergen Drug Corp on December 15, 2025, for the supply of Vemlidy 25 mg tablets (30-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of December 16, 2025. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order operates under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 2, 2025, for the supply of Vemlidy 25 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with a ceiling value of $2,703.17 and an ultimate completion date of December 3, 2025. The award was not set-aside and was competitively awarded, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child...
- SPE2DR25D3103Indefinite Delivery Contract
- SPE2DR25D3103-SPE2DR26F9R96Delivery Order
The Defense Logistics Agency awarded a $226,409.59 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Vemlidy 25 mg tablets (30-count units) with an ultimate completion date of December 23, 2025. This non-set-aside competitive award was issued on December 22, 2025, with performance at the contractor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, fulfills this order under its existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.9 billion global pharmaceutical support vehicle running through December 2026 that enables the company to supply pharmaceutical products and medical supplies across multiple therapeutic domains to support military healthcare programs worldwide. This delivery order represents a routine pharmaceutical procurement within AmerisourceBergen Drug Corp's extensive portfolio of federal medical supply deliveries to the Defense Health Agency and related military healthcare systems. The award demonstrates the contractor's continued capability to meet federal requirements through open competition, consistent with DLA's strategic procurement approach for pharmaceutical commodities supporting the Department of Defense medical supply chain. The delivery order is classified as a child contract under the larger SPE2DX IDC vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $226.4k | 12/21/25 |